Journal
FRONTIERS IN ONCOLOGY
Volume 12, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fonc.2022.848107
Keywords
(-)-epigallocatechin-3-gallate; microbiota; radiation-induced intestinal injuries; beneficial bacteria; dysbiosis
Categories
Ask authors/readers for more resources
EGCG has been shown to attenuate radiation-induced intestinal injury (RIII). This study reveals that EGCG administration reduces radiation-induced intestinal mucosal injury and promotes the proliferation of intestinal stem cells. Additionally, EGCG can reverse radiation-induced gut dysbiosis and increase the abundance of beneficial bacteria, suggesting that EGCG may be a potential modulator of gut microbiota to prevent and treat RIII.
The high radiosensitivity of the intestinal epithelium limits the outcomes of radiotherapy against abdominal malignancies, which results in poor prognosis. Currently, no effective prophylactic or therapeutic strategy is available to mitigate radiation toxicity in the intestine. Our previous study revealed that the green tea polyphenol (-)-epigallocatechin-3-gallate (EGCG) attenuates radiation-induced intestinal injury (RIII). The aim of the present study was to determine the effect of EGCG on the intestinal flora of irradiated mice. EGCG administration reduced radiation-induced intestinal mucosal injury, and significantly increased the number of Lgr5(+) intestinal stem cells (ISCs) and Ki67(+) crypt cells. In addition, EGCG reversed radiation-induced gut dysbiosis, restored the Firmicutes/Bacteroidetes ratio, and increased the abundance of beneficial bacteria. Our findings provide novel insight into EGCG-mediated remission of RIII, revealing that EGCG could be a potential modulator of gut microbiota to prevent and treat RIII.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available